Pharmaceutical Giant Johnson & Johnson Acquires Robotic-Surgery Firm Auris for $3.4 Billion
- Published | 15 February 2019
Johnson & Johnson is bulking up on its surgical robotics presence by acquiring Auris Surgical Robotics for $3.4 billion is all set to push the growing Artificial Intelligence market in Healthcare.
Global: Johnson & Johnson is purchasing privately held surgical robotic technologies manufacturer Auris Health for about $3.4 billion in cash. Another $2.35 billion could be added to the deal in aggregate if the company will reach certain undisclosed milestones. Auris is currently focusing on lung cancer treatment and has developed robotic surgical scopes operated with a handheld device that is steered into patients’ lungs to identify cancerous tumors.
Auris will now be a part of J&J’s medical-devices division. J&J, the world’s largest maker of health-care products, also has a robotic-surgery company called Verb Surgical Inc. that it formed with Verily Life Sciences, part of Google parent Alphabet Inc., in late 2015.
Moll will also join J&J after the closing of this acquisition, which is expected by the end of the second quarter. He was the founder of Intuitive Surgical Inc., a pioneer in robotic laparoscopic surgery tools, now valued around $60 billion. Through this acquisition, in this new era of health care, it can help to simplify surgery, drive efficiency, reduce complications and improve outcomes for patients, ultimately making surgery safer.

Related Blog
- Prebiotics consumption expands in food and beverage applications...
- Online education industry – How has COVID-19 impacted the growth dynamics
- Lithium ion batteries continue to gain phenomenal traction in the automotive sector...
- Personal Protective Equipment Industry – 6 Major Application Sectors Driving...